Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial

Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial

Abstract Introduction Chronic hepatitis B (CHB) is a global public health problem. Antiviral therapy is the primary treatment. Studies have shown that a combined therapy of traditional Chinese medicine (TCM) and conventional antiviral drugs has better efficacy than conventional antiviral for treatme...

Full description

Bibliographic Details
Main Authors: Qing-Juan Wu, Wen-Liang Lv, Juan-Mei Li, Ting-Ting Zhang, Wen-hui Zhou, Qiang Zhang, Jiu-Chong Wang, Qing-Nan Wang, Ruo-Xuan Zhang, Xin Zhao, Si-Tong Chen, Shuang Liu, Gao-Hui Li, Zheng-Min Cao, Lei Xu, Jing Chen
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Chronic hepatitis B
Cirrhosis
Traditional Chinese medicine
Clinical trial
Efficacy
Online Access:http://link.springer.com/article/10.1186/s13063-020-04395-y

Internet

http://link.springer.com/article/10.1186/s13063-020-04395-y

Similar Items